Sector revisions Kymera Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2026 BST			5-day change	1st Jan Change
82.21 ^USD	-2.71%		-4.50%	+5.65%

05-15	Kymera Therapeutics announces presentations on KT-621, a first-in-class, oral Stat6 degrader, at the Society for Investigative Dermatology and American Thoracic Society congresses	RE
05-12	Kymera Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 09:20 AM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Nbr of analysts
KYMERA THERAPEUTICS, INC.			22
LONZA GROUP AG			23
BEONE MEDICINES AG			27
REVOLUTION MEDICINES, INC.			20
IQVIA HOLDINGS INC.			20
CELLTRION, INC.			24
ASCENDIS PHARMA A/S	-	-	15
IONIS PHARMACEUTICALS, INC.			23
EUROFINS SCIENTIFIC SE			14
MEDPACE HOLDINGS, INC.			12
PRAXIS PRECISION MEDICINES, INC.			17
ABIVAX			7
ICON PUBLIC LIMITED COMPANY			14
TEMPUS AI, INC.			15
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			15
BACHEM HOLDING AG			10
QIAGEN N.V.			14
BIO-TECHNE CORPORATION			12
PHARMARON BEIJING CO., LTD.			12
Average			17
Weighted average by Cap.			19